Yuheng Pharmaceutical: The bankruptcy and reorganization of the company's controlling shareholder is still in the process of progress, and there is no substantial progress yet.

Post date April 12, 2022 — 10:57 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Jufeng Early Participation: Shanghai resumption of business and market + lower mortgage interest rate lower limit, A shares will fluctuate upward

May 16, 2022 — 03:29

Yuheng Pharmaceutical: A fire accident occurred in a three-dimensional warehouse of a subsidiary – yqqlm

May 13, 2022 — 18:39

A fire accident occurred in a three-dimensional warehouse of a subsidiary of Yuheng Pharmaceutical Co., Ltd.

May 13, 2022 — 18:38

[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks’ revenue and net profit will double, and BeiGene will become the “loss king” – yqqlm

May 1, 2022 — 04:00

[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks will increase in revenue and net profit, and BeiGene will become the "loss king"-Stock Channel-Hexun.com

May 1, 2022 — 04:00

The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG

April 19, 2022 — 09:35

The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua

April 19, 2022 — 09:30

The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina

April 19, 2022 — 07:36

The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG_Individual Stock Information_Market Gold Online

April 19, 2022 — 07:31

Home » News » Yuheng Pharmaceutical: The bankruptcy and reorganization of the company's controlling shareholder is still in the process of progress, and there is no substantial progress yet.